Drug reference
Immunisation against anthrax ▶BY INTRAMUSCULAR INJECTION ▶Adult: Initially 0.5 mL every 3 weeks for 3 doses, followed by 0.5 mL after 6 months, to be administered in the deltoid region Booster ▶BY INTRAMUSCULAR INJECTION ▶Adult: 0.5 mL every 10 years for up to 3 doses, to be administered in deltoid region
PDF page 1404
Available from Public Health England’s Centre for Emergency Preparedness and Response (Porton Down).
PDF page 1404
▶Common or very common Febrile disorders. influenza like illness ▶Rare or very rare Angioedema. asthenia. hyperhidrosis. paraesthesia ▶Frequency not known Bronchospasm. circulatory collapse. hypotension
PDF page 1404
There can be variation in the licensing of different medicines containing the same drug. Suspension for injection EXCIPIENTS: May contain Thiomersal ▶Anthrax vaccine (Non-proprietary) Anthrax vaccine (alum precipitated sterile filtrate) suspension for injection 0.5ml ampoules | 5 ampoule P s ▶BioThrax (Secretary of State for Health) A BioThrax suspension for injection 5ml multidose vials | 1 vial P £751.71 | 300 vial P £225,513.09 eiiii F 1379
PDF page 1404
Initially 0.5 mL every 3 weeks for 3 doses,
First-line fragment. Read the complete Indications and Dose section above.
PDF page 1404
0.5 mL every 10 years for up to 3 doses, to be
First-line fragment. Read the complete Indications and Dose section above.
PDF page 1404
